Cisplatin

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  

Cisplatin
Apr 4, 2025, 09:15 | Blog
Tian Zhang: Best practices for second line treatment in Metastatic Urothelial Carcinoma
Tian Zhang, Associate Professor in the Department of Internal Medicine at UT Southwestern Medical Center, shared…
Feb 27, 2025, 10:03 | Blog
Tanja Obradovic: New option of immunotherapy for HNSCC is on the horizon
Tanja Obradovic, Vice President of Oncology Scientific Affairs at ICON PLCh, shared a post on…
Feb 18, 2025, 19:32 | Blog
Sabine D. Brookman-May: Updated analysis with additional FU of EV 302 in 1st line advanced Bladder Cancer
Sabine D. Brookman-May, Senior Vice President and Therapeutic Area Head of Urologic Oncology at Aura…
Jan 30, 2025, 06:19 | Insight
Senthil Kumar: First-Line Therapy for Advanced/Metastatic Penile Cancer
Senthil Kumar, Medical Oncologist at Red Hills Chennai, shared a post on X: "First-Line Therapy…
Jan 15, 2025, 15:12 | Insight
Senthil Kumar: First-Line Systemic Treatment for Advanced/Metastatic Salivary Gland Tumors
Senthil Kumar, Medical Oncologist at Red Hills Chennai, shared a post on X: “First-Line Systemic…
Jan 11, 2025, 14:58 | Insight
Senthil Kumar: Comprehensive Overview of First-Line Treatment for Metastatic Anal Cancer
Senthil Kumar, Medical Oncologist at Red Hills, Chennai shared a post on X: “Comprehensive Overview…
Dec 11, 2024, 13:04 | Insight
Gustavo Viani: How to approach GEJ adenocarcinoma
Gustavo Viani, Professor of Radiation Oncology at Ribeirão Preto Medical School, University of Sao Paulo,…
Dec 8, 2024, 06:30 | Insight
Tom Powles: Cisplatin or Carboplatin-Based Chemotherapy with Pembrolizumab in Advanced Urothelial Cancer
Tom Powles, Director of Barts Cancer Centre, shared a recent article on X: "While EVP…
Dec 4, 2024, 13:07 | Insight
Gold-Based Drug Shows Potential for Targeted, Less Toxic Cancer Treatment
Gold-Based Drug Slows Tumor Growth by 82%, Offering Hope for Less Toxic Cancer Treatments. A…
Nov 29, 2024, 18:49 | Insight
Dr. Reddy’s has launched Toripalimab in India: Advancing Treatment for Nasopharyngeal Carcinoma
Reddy’s Laboratories Ltd. has announced the launch of Toripalimab, the first and only immuno-oncology drug…
Nov 19, 2024, 12:50 | Blog
Robin Zon: Celebrating Larry Einhorn's 50th Anniversary for the cure for testicular cancer
Robin Zon shared a post on LinkedIn: "The Congratulations to Dr Larry Einhorn on the 50th…
Nov 15, 2024, 15:10 | Insight
Five articles suggested by Yüksel Ürün
Yüksel Ürün is a Medical Oncology professor at Ankara University School of Medicine in Turkey.…
Oct 11, 2024, 19:37 | Insight
María Natalia Gandur Quiroga: Mutations and DNA Structures Driving Bladder Cancer
María Natalia Gandur Quiroga recently shared a post on LinkedIn: “Study Uncovers Mutations and DNA…
Oct 6, 2024, 16:44 | Insight
Amrubicin + irinotecan vs cisplatin + irinotecan for SCLC
Stephen V Liu shared a post on X: "Randomized phase II: 1L amrubicin + irinotecan vs…
Oct 6, 2024, 12:22 | Insight
Stephen V Liu: Randomized phase II trial results on amrubicin vs cisplatin for SCLC
Stephen V Liu posted the following on X: “Randomized phase II: 1L amrubicin + irinotecan…
Oct 5, 2024, 16:01 | Insight
Once-a-Week Versus Once-Every-3-Weeks Cisplatin Along With Radiation in Head and Neck Cancer
European Society for Radiotherapy and Oncology (ESTRO) shared a post on LinkedIn: “Long-Term Update of…
Sep 27, 2024, 16:51 | Blog
Aren Karapetyan: New study on nasopharyngeal carcinoma shows improved outcomes with Nedaplatin
Aren Karapetyan, Oncology Resident at Yerevan State Medical University, shared the following on LinkedIn: “New study…
Sep 24, 2024, 08:51 | Insight
Aren Karapetyan: New Insights on Treatment for Squamous Cell Carcinoma of the Anus
Aren Karapetyan, Oncology Resident at Yerevan State Medical University, shared a post on LinkedIn: "New…
Sep 1, 2024, 14:50 | Blog
Sandro Porceddu: Even low dose cisplatin has an impact on sensorineural hearing loss
Sandro Porceddu, Director of the Department of Radiation Oncology at Peter MacCallum Cancer Centre, shared…
Aug 22, 2024, 05:55 | Celebrities
Lance Armstrong and Testicular Cancer: Story, Symptoms, Treatment
Lance Armstrong, born on September 18, 1971, in Plano, Texas, is a former professional road…
Jul 20, 2024, 22:54 | Blog
David S. Miller: Why Cisplatin should not be added to radiotherapy for certain recurrent Endometrial Cancer
David Scott Miller, Gynaecologic Oncologist and Professor at Department of Obstetrics and Gynaecology at UT…
Jul 8, 2024, 12:15 | Insight
Neeraj Agarwal: Authoritative talk on systemic treatment of penile cancer by Andrea Necchi
Neeraj Agarwal shared a post on X: "Authoritative talk on systemic treatment of penile cancer…
Jun 26, 2024, 14:10 | Blog
Maria Babak: Rapid Progress in Metastatic Urothelial Carcinoma
Maria Babak shared a post by The Babak Lab on LinkedIn: “The FDA's approval of…
Jun 2, 2024, 07:40 | Blog
Deep lamichhane: Bhaktapur Cancer Hospital is the only center offering HIPEC service in Nepal
Deep lamichhane, Consultant at Department of Surgical Oncology at Norvic Hospital, shared on X/Twitter: "11th…
May 23, 2024, 13:08 | Blog
Miguel Bronchud: Too many different treatments options for some cancer patients? Or not enough?
Miguel Bronchud, Co-Founder of Regenerative Medicine Solutions, shared on LinkedIn: “Too many different treatments options…
May 22, 2024, 03:53 | Drugs
Tanja Obradovic: FDA just announced withdrawal of the approval for BridgeBio Pharma Truseltiq
Tanja Obradovic shared a post on LinkedIn: “FDA just announced withdrawal of the approval for BridgeBio…
May 21, 2024, 08:21 | Societies
20 Posts Not To Miss From SIOP Europe 2024!
The 5th SIOP Europe Annual Meeting took place in Milan, Italy on 13-17 May 2024.…
May 21, 2024, 05:24 | Blog
Kim Jones: Fennec Pharmaceuticals Inc and TCAF are working together to raise awareness of ototoxicity from Cisplatin
Kim Jones, CEO and Founder at Testicular Cancer Awareness Foundation, shared a post on LinkedIn:…
May 18, 2024, 06:36 | Blog
Shushan Hovsepyan: Cisplatin induced ototoxicity is a serious complication
Shushan Hovsepyan shared a post on X/Twitter: ''Cisplatin - induced ototoxicity is a serious complication! Irreversible,…
Apr 8, 2024, 22:37 | Insight
Key Message Highlights from Phase II Trial of Cisplatin, Gemcitabine, and Intensity-Modulated Radiation Therapy for Locally Advanced Vulvar Squamous Cell Carcinoma
Phase II Trial of Cisplatin, Gemcitabine, and Intensity-Modulated Radiation Therapy for Locally Advanced Vulvar Squamous…
Apr 8, 2024, 22:27 | Insight
Adjuvant Therapy for Urothelial Cancer in Advances in Oncology - New Paper Alert!
Adjuvant Therapy for Muscle-Invasive Urothelial Cancer: Current Evidence and Future Directions   Authors: Charbel Hobeika,…
Apr 5, 2024, 08:35 | Insight
Bishal Gyawali: Why 'number of cancer drugs approved' is a poor surrogate for measuring policy success
Alvaro Carrascal, Assistant Professor at University at Albany School of Public Health, shared a post…
Apr 1, 2024, 15:31 | Blog
Tom Powles: Easter paper of the month with Matt Galsky
Tom Powles, Director of Barts Cancer Center, shared a post on X: "Easter paper of…
Mar 26, 2024, 13:13 | Blog
Timothée Olivier: Important findings for health policy
Timothée Olivier, Medical Oncologist at HUG – Geneva University Hospitals, recently shared on X/Twitter: “Out…
Mar 7, 2024, 17:22 | Insight
Mohammad Jad Moussa: The new EVP 'fissure' challenges the dichotomy of cisplatin/platinum fitness
Mohammad Jad Moussa, Postdoc Fellow of GU Oncology at MD Anderson Cancer Center, shared on…
Feb 11, 2024, 12:01 | Insight
Vinay Mathew Thomas: Our viewpoint article on CheckMate 901 is now out in Med by Cell Press
Petros Grivas, Associate Professor at the University of Washington, shared an X post by Vinay…
Jan 5, 2024, 11:46 | Blog
Petros Grivas: This is a product of teamwork for many years
Petros Grivas, Associate Professor at University of Washington, shared on X/Twitter: "This is a product of…
Dec 21, 2023, 10:24 | Insight
Erman Akkus: 2023 updated MASCC and ESMO recommendations for prophylaxis of nausea and vomiting
Erman Akkus, Medical Oncology Fellow at Ankara University, shared on X/Twitter: "2023 updated MASCC and ESMO…
Nov 14, 2023, 03:56 | Insight
Guru P. Sonpavde: Honored to write this commentary...
Guru P. Sonpavde, GU Oncology Director at Advent Health Cancer Institute, shared on X/Twitter: "Nivolumab…
Nov 5, 2023, 04:38 | Blog
Nils Nicolay: Our new multicenter data will help to further clarify the role of definitive chemoradiation in elderly HNSCC patients
Nils Nicolay, Professor and Chair of the Department of Radiation Oncology at the University of…
Jul 5, 2023, 05:23 | Drugs
Cancer drug shortages continue - Stephen V Liu
Cancer drug shortages continue. Carboplatin, cisplatin, capecitabine, methotrexate, azacitadine - the list continues to grow…
Jun 24, 2023, 16:40 | Drugs
Short on cisplatin - Don S. Dizon
Short on cisplatin, treatment decisions are being impacted. And it does not feel good. At…
Jun 7, 2023, 03:37 | Drugs
Addressing Cisplatin and Carboplatin Shortages: Insights from FDA Oncology Center of Excellence Director
In this open access discussion, Richard Pazdur, Director of the FDA Oncology Center of Excellence,…
All: 43 Posts: 1 - 100
Special Coverage